These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy. Lee KS; Liu JY; Wagner KM; Pakhomova S; Dong H; Morisseau C; Fu SH; Yang J; Wang P; Ulu A; Mate CA; Nguyen LV; Hwang SH; Edin ML; Mara AA; Wulff H; Newcomer ME; Zeldin DC; Hammock BD J Med Chem; 2014 Aug; 57(16):7016-30. PubMed ID: 25079952 [TBL] [Abstract][Full Text] [Related]
6. Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern. Ostermann AI; Herbers J; Willenberg I; Chen R; Hwang SH; Greite R; Morisseau C; Gueler F; Hammock BD; Schebb NH Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):131-7. PubMed ID: 26117215 [TBL] [Abstract][Full Text] [Related]
7. Meloxicam fails to augment the reno-protective effects of soluble epoxide hydrolase inhibition in streptozotocin-induced diabetic rats via increased 20-HETE levels. Katary MM; Pye C; Elmarakby AA Prostaglandins Other Lipid Mediat; 2017 Sep; 132():3-11. PubMed ID: 27596333 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain. Inceoglu B; Jinks SL; Schmelzer KR; Waite T; Kim IH; Hammock BD Life Sci; 2006 Nov; 79(24):2311-9. PubMed ID: 16962614 [TBL] [Abstract][Full Text] [Related]
9. Small Molecule Soluble Epoxide Hydrolase Inhibitors in Multitarget and Combination Therapies for Inflammation and Cancer. Das Mahapatra A; Choubey R; Datta B Molecules; 2020 Nov; 25(23):. PubMed ID: 33255197 [TBL] [Abstract][Full Text] [Related]
14. Further exploration of the structure-activity relationship of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors. Wilt S; Kodani S; Valencia L; Hudson PK; Sanchez S; Quintana T; Morisseau C; Hammock BD; Kandasamy R; Pecic S Bioorg Med Chem; 2021 Dec; 51():116507. PubMed ID: 34794001 [TBL] [Abstract][Full Text] [Related]
15. Endoplasmic reticulum stress in the peripheral nervous system is a significant driver of neuropathic pain. Inceoglu B; Bettaieb A; Trindade da Silva CA; Lee KS; Haj FG; Hammock BD Proc Natl Acad Sci U S A; 2015 Jul; 112(29):9082-7. PubMed ID: 26150506 [TBL] [Abstract][Full Text] [Related]
16. EETs/sEHi alleviates nociception by blocking the crosslink between endoplasmic reticulum stress and neuroinflammation in a central poststroke pain model. Liu T; Li T; Chen X; Li Z; Feng M; Yao W; Wan L; Zhang C; Zhang Y J Neuroinflammation; 2021 Sep; 18(1):211. PubMed ID: 34530836 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of soluble epoxide hydrolase by fulvestrant and sulfoxides. Morisseau C; Pakhomova S; Hwang SH; Newcomer ME; Hammock BD Bioorg Med Chem Lett; 2013 Jul; 23(13):3818-21. PubMed ID: 23684894 [TBL] [Abstract][Full Text] [Related]
18. Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress. Ren Q; Ma M; Ishima T; Morisseau C; Yang J; Wagner KM; Zhang JC; Yang C; Yao W; Dong C; Han M; Hammock BD; Hashimoto K Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1944-52. PubMed ID: 26976569 [TBL] [Abstract][Full Text] [Related]